Autoryzacja wymagana
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay
A.D. Ho
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolAtlanta,
Wyszukaj tego autora
H. Verkerke
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolAtlanta,
Wyszukaj tego autora
J.W. Allen
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolAtlanta,
Wyszukaj tego autora
B.J. Saeedi
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
D. Boyer
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
J. Owens
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
S. Shin
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
M. Horwath
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
K. Patel
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
Wyszukaj tego autora
A. Paul
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
Wyszukaj tego autora
S.-C. Wu
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
Wyszukaj tego autora
S. Chonat
Department of Pediatrics, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
P. Zerra
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
,
J.D. Roback
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
A. Neish
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
C.D. Josephson
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
C.M. Arthur
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
Wyszukaj tego autora
S.R. Stowell
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolAtlanta,
Wyszukaj tego autora
31 mar 2021
O artykule
Zacytuj
Udostępnij
Pobierz okładkę
Kategoria artykułu: article
Data publikacji: 31 mar 2021
Zakres stron: 33 - 43
DOI: https://doi.org/10.21307/immunohematology-2021-007
Słowa kluczowe
© 2021 A.D. Ho et al., published by Sciendo
- Język:
- Angielski
- Częstotliwość wydawania:
- 4 razy w roku
- Dziedziny czasopisma:
- Medycyna, Medycyna kliniczna, Medycyna laboratoryjna